Microdose Psychedelic Capital Conference Insights| MENAFN.COM

Saturday, 13 August 2022 06:42 GMT

Microdose Psychedelic Capital Conference Insights


(MENAFN- Investor Brand Network)

Microdose Psychedelic Insights , the premier global guide to the business of psychedelics, hosted a successful Psychedelic Capital Conference in an entirely virtual format, Tuesday, July 26, 2022.

The July edition of the Microdose event introduced the investors and attendees to top investors, entrepreneurs, psychedelic researchers, latest IPO and health leaders, sharing valuable insights into the psychedelic sector. Part of a bimonthly investor conference series that dives deep into…

Read More>>

To learn more, please visit .

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you'll need to ensure that your next press release grabs the attention of your target audience and doesn't let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire's syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit 

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: 

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office

InvestorWire is part of the InvestorBrandNetwork .

MENAFN05082022000224011066ID1104653320


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.